Topics

AstraZeneca to sell global rights for Losec in $276M deal

06:30 EDT 2 Oct 2019 | SmartBrief

Germany's Cheplapharm Arzneimittel will acquire global commercial rights, except for the US, China, Japan and Mexico, to Astr -More

Original Article: AstraZeneca to sell global rights for Losec in $276M deal

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca to sell global rights for Losec in $276M deal"

Quick Search